Episodes — Biotech2050 Podcast

Ep. 24 - JoyL Silva & Nicole Strauss, General Manager and Pipeline Development & Innovation Lead, Pfizer CentreOne

JoyL is the General Manager of Pfizer CentreOne, a global contract development and manufacturing organization (CDMO) and a leading supplier of specialty APIs embedded within Pfizer. Nicole is Pfizer CentreOne’s Pipeline Development and Innovation Lead. In this role, Nicole has responsibility for assessing competitive intelligence to identify growth opportunities across the Pfizer CentreOne businesses, lead technical and regulatory assessments of pipeline projects and provide development services to meet customer needs.

Rahul ChaturvediAugust 2, 2020Biotech, Biopharma, Entrepreneur, Startup, Innovation, Rare Diseases

Ep. 23 - Abbas Kazimi, VP of Business Development, Nimbus Therapeutics

Abbas Kazimi is the Vice President, Head of Business Development at Nimbus Therapeutics, a biotechnology company harnessing quantum mechanics and computational approaches to structural biology to design breakthroughs in medicine.

Alok TayiAugust 2, 2020Biotech, Biopharma, Entrepreneur, Startup, Innovation, Rare Diseases

Ep. 20 - Diego Ardigo, Head of R&D, Global Rare Diseases, Chiesi Group

Diego is currently the Head of Research & Development of Global Rare Diseases at the Chiesi Group. Before this role, he was leading Chiesi’s development projects in rare diseases and advanced therapies and has more than 10 years experience in drug development, spanning from pre-clinical to commercial phase.

Alok TayiJuly 29, 2020Biotech, Biopharma, Entrepreneur, Startup, Innovation, Rare Diseases

Ep. 22 - Randy Schatzman, PhD, CEO of Bolt Biotherapeutics

Dr. Randy Schatzman, Ph.D., is the chief executive officer and a board member of Bolt Biotherapeutics since 2019. He has over 30 years of biotechnology experience. Prior to Bolt, Dr. Schatzman was president and CEO, co-founder and board member of Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), from 2004 to 2018.

Rahul ChaturvediJuly 29, 2020Biotech, Biopharma, Entrepreneur, Startup, Innovation, Rare Diseases

Ep. 21 - Glenn Rosen, MD, SVP of Pre-clinical and Translational Sciences, Coherus Biosciences

Dr. Glenn Rosen has spent the bulk of his career engaged in basic and translational research in cancer and fibrosis. From 1993-2014, Dr. Rosen held a tenured faculty position in the Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University.

Rahul ChaturvediJuly 1, 2020Biotech, Biopharma, Entrepreneur, Startup, Innovation, Rare Diseases

Ep. 19 - Mike Clayman M.D., President and CEO, Flexion Therapeutics

Dr. Clayman is a co-founder of Flexion Therapeutics and has served as our President, Chief Executive Officer and as one of our directors since our inception in 2007. Dr. Clayman also serves as the Chairman of the board of directors of both Anokion SA and Ribometrix.

Alok TayiJuly 1, 2020Biotech, Biopharma, Entrepreneur, Startup, Innovation

Ep. 18 - Grace Colón PhD, President and CEO, InCarda Therapeutics

Dr. Colón brings over 25 years of experience in biopharma, genomics, healthcare and industrial biotechnology. In addition to her role at InCarda, she is Executive Chairman (formerly CEO) of ProterixBio, and serves on the boards of CareDx (NASDAQ:CDNA) and Cocoon Biotech and on the Advisory Board of the Miller Center for Social Entrepreneurship at Santa Clara University.

Rahul ChaturvediJuly 1, 2020Biotech, Biopharma, Entrepreneur, Startup, Medical Devices

Ep. 17 - Sachin Chandran PhD, Head of Pharmaceutical Sciences, Catabasis

Recorded in January 2020, we spoke with Sachin Chandran, who is currently Executive Director and Head of Pharmaceutical Sciences at Catabasis Pharmaceuticals, Inc. in Boston. Sachin’s responsibilities include oversight of CMC, Tech-Ops and supply chain along with matrixed interactions with regulatory, quality, biology, clinical and commercial.

Alok TayiJune 10, 2020Biotech, Biopharma, Entrepreneur, Startup, CMC, Manufacturing

Ep. 16 - Mike Novotny, Founder & Chief Executive Officer, Medrio

Mike Novotny is the founder and CEO of Medrio. Mr. Novotny applies 20 years of experience in research and software to his eClinical SaaS vision. Prior to founding Medrio, Mr. Novotny was president of Ninaza, an EDC software company, and had previously held roles as a research associate at the U.N. and a manager of the fraud database at VISA.

Alok TayiJune 4, 2020Biotech, Biopharma, Entrepreneur, Startup, Clinical, Clinical Trials, EDC

Ep. 15 - David Mace, Chief Executive Officer, SwiftScale Bio

David Mace is the Co-founder & CEO of SwiftScale Biologics, a life sciences startup based in San Francisco, California. SwiftScale Biologics accelerates time to market for protein drugs by turning a labor-intensive drug production scale-up challenge into a computational challenge.

Guest UserMay 26, 2020Biotech, Biopharma, Entrepreneur, Startup, Biologics, Manufacturing

Ep. 14 - David Bates, Chief Executive Officer, Linus Health

David Bates is a scientist, inventor, investor, and entrepreneur. He has co-founded several companies including Linus Health and Bode. He is a founding partner of Tamarisc Ventures and serves on the board of several high-growth technology companies. He is on the board of directors of TMCity Foundation and is Strategic Advisor to the Digital Medicine Society.

Alok TayiMay 21, 2020Biotech, Clinical, Biopharma, Entrepreneur, Startup, CNS, Digital Health

Ep. 13 - Stephan Kontos, Chief Scientific Officer, Anokion Therapeutics

Stephan is a Co-Founder and Chief Scientific Officer at Anokion, bringing more than 15 years of research expertise in the fields of immunology, protein engineering, and platform technologies to the company. He earned his B.Sc. in Chemical Engineering from the University of Texas at Austin and a Ph.D. in Bioengineering.

Rahul ChaturvediMay 14, 2020Biotech, Clinical, Biopharma, Entrepreneur, Startup